Bank of New York Mellon Corp - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$5,527,000
+122.2%
307,215
-11.9%
0.00%0.0%
Q1 2020$2,487,000
-66.6%
348,810
+11.7%
0.00%
-50.0%
Q4 2019$7,457,000
-9.9%
312,249
+1.2%
0.00%0.0%
Q3 2019$8,275,000
+9.8%
308,541
+11.0%
0.00%0.0%
Q2 2019$7,539,000
-24.2%
277,891
-3.1%
0.00%
-33.3%
Q1 2019$9,949,000
+77.0%
286,730
-0.4%
0.00%
+50.0%
Q4 2018$5,622,000
-43.6%
288,014
-23.0%
0.00%
-33.3%
Q3 2018$9,964,000
-33.4%
374,219
-5.5%
0.00%
-25.0%
Q2 2018$14,964,000
+15.3%
396,163
-0.3%
0.00%0.0%
Q1 2018$12,983,000
-29.4%
397,532
+5.2%
0.00%
-20.0%
Q4 2017$18,402,000
+2.0%
378,006
+13.2%
0.01%0.0%
Q3 2017$18,045,000
+15.7%
334,027
+20.3%
0.01%
+25.0%
Q2 2017$15,596,000
+58.7%
277,642
+10.7%
0.00%
+33.3%
Q1 2017$9,825,000
+88.3%
250,723
+7.8%
0.00%
+50.0%
Q4 2016$5,218,000
+3.1%
232,512
+4.3%
0.00%0.0%
Q3 2016$5,062,000
-15.4%
222,903
-12.1%
0.00%0.0%
Q2 2016$5,986,000
+17.4%
253,641
+1.5%
0.00%0.0%
Q1 2016$5,099,000
-66.4%
249,949
-15.4%
0.00%
-60.0%
Q4 2015$15,194,000
+34.2%
295,316
+11.2%
0.01%
+66.7%
Q3 2015$11,322,000
-5.9%
265,641
+0.5%
0.00%0.0%
Q2 2015$12,037,000
+26.7%
264,273
+5.6%
0.00%
+50.0%
Q1 2015$9,502,000
+49.9%
250,318
+11.9%
0.00%0.0%
Q4 2014$6,338,000
+9.1%
223,795
-2.6%
0.00%0.0%
Q3 2014$5,810,000
-46.9%
229,822
-38.7%
0.00%
+100.0%
Q2 2014$10,938,000
+311.4%
374,858
+265.1%
0.00%0.0%
Q1 2014$2,659,000
+4.2%
102,661
+3.6%
0.00%0.0%
Q4 2013$2,553,000
+13.7%
99,123
+18.0%
0.00%
Q3 2013$2,246,000
+92.6%
84,014
+77.0%
0.00%
Q2 2013$1,166,00047,4560.00%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,220,672$55,602,0009.30%
Fernwood Investment Management, LLC 201,211$9,165,0007.20%
Cormorant Asset Management, LP 500,000$22,775,0003.03%
Ghost Tree Capital, LLC 170,000$7,744,0002.51%
HARVEY CAPITAL MANAGEMENT INC 155,030$7,108,0002.40%
SECTORAL ASSET MANAGEMENT INC 1,169,130$53,254,0002.22%
Atika Capital Management LLC 98,000$4,464,0002.01%
Temasek Holdings (Private) Ltd 5,833,568$265,719,0001.66%
CABOT WEALTH MANAGEMENT INC 124,309$5,662,0001.38%
EMERALD MUTUAL FUND ADVISERS TRUST 314,689$14,334,0001.11%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders